• OPEN AN ACCOUNT
Indian Indices
Nifty
25,453.40 -88.40
(-0.35%)
Sensex
83,409.69 -287.60
( -0.34%)
Bank Nifty
56,999.20 -460.25
( -0.80%)
Nifty IT
38,879.10 45.95
( 0.12%)
Global Indices
Nasdaq
44,498.76 -17.19
(-0.04%)
Dow Jones
6,247.07 28.06
(0.45%)
Hang Seng
39,758.37 -227.96
(-0.57%)
Nikkei 225
8,774.69 -10.64
(-0.12%)
Forex
USD-INR
85.62 0.21
(0.25%)
EUR-INR
100.54 0.47
(0.47%)
GBP-INR
117.42 0.25
(0.22%)
JPY-INR
0.59 0.00
(0.57%)

EQUITY - MARKET SCREENER

Aatmaj Healthcare Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
78782
INE0OB201016
22.1769912
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AATMAJ
68.93
43.62
EPS(TTM)
Face Value()
Div & Yield %
0.28
5
0.26
 

reliance industrial infrastructure ltd
Maruti Suzuki sales dip 6.27% YoY to 167,993 units in June’25
Jul 02,2025

The sales of domestic passenger vehicles stood at 1,18,906 units (down 13.30% YoY), while sales of light commercial vehicles came in at 2,433 units (down 11.78% YoY) during the period under review.

While the company's total domestic sales (PV+LCV+OEM) declined 12.17% YoY to 1,30,151 units, total export sales increased by 21.94% YoY to 37,842 units sold in June 2025.

Meanwhile, the car manufacturer’s total production fell 4.16% to 1,27,545 units in June 2025 as against 1,33,095 units recorded in June 2024.

In June’25, the production of passenger vehicles was at 1,25,392 units, down 4.22% from 1,30,930 units produced in June 2024. Additionally, the production of light commercial vehicles reached 2,153 units in June 2025, registering a YoY decline of 0.55%.

Maruti Suzuki India is engaged in the manufacture, purchase, and sale of motor vehicles, components, and spare parts (automobiles).

The company has reported 4.3% fall in standalone net profit to Rs 3,711.1 crore despite a 5.9% increase in net sales to Rs 38,848.8 crore in Q4 FY25 as compared with Q4 FY24.

Shares of Maruti Suzuki India rose 0.02% to Rs 12,445 on the BSE.